LEXX logo

Lexaria Bioscience (LEXX) Selling, General & Administrative Expenses

Annual SGA

$3.85 M
+$790.00 K+25.80%

August 31, 2024

Summary

Performance

1-Year Change

+25.8%

3-Year Change

-22.52%

5-Year Change

+5.73%

15-Year Change

+110.14%

LEXX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

4.43%
LEXX annual SGA is higher than 4.43% of companies in Healthcare sector

High & Low

All-time High

$6.51 M
LEXX annual SGA is currently -40.86% below its historical high of $6.51 million

3-Year Low

$3.06 M
LEXX annual SGA is currently +25.80% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Aug 31, 2024
LEXX previous annual earnings announcement was published on Aug 31, 2024

Next Annual Earnings Report Date

N/A
LEXX next annual earnings announcement has not yet been scheduled

OtherLEXXexpensesmetrics:

Annual Total Expenses

$6.22 M
LEXX annual total expenses is $6.22 million

Annual Operating Expenses

$6.21 M
LEXX annual total operating expenses is $6.21 million

Annual Cost Of Goods Sold

$4800.00
LEXX annual cost of goods sold is $4800.00

Annual Interest Expense

-
LEXX annual interest expense value is unknown

Quarterly SGA

$918.70 K
-$401.20 K-30.40%

November 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-3.08%

5-Year Change

-3.08%

LEXX Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

4.84%
LEXX quarterly SGA is higher than 4.84% of companies in Healthcare sector

High & Low

All-time High

$3.47 M
LEXX quarterly SGA is currently -73.49% below its historical high of $3.47 million

3-Year Low

$462.30 K
LEXX quarterly SGA is currently +98.72% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Nov 30, 2024
LEXX previous earnings announcement was published on Nov 30, 2024

Next Quarterly Earnings Report Date

Apr 9, 2025
LEXX next earnings announcement is scheduled for Apr 9, 2025

OtherLEXXexpensesmetrics:

Quarterly Total Expenses

$2.87 M
LEXX quarterly total expenses is $2.87 million

Quarterly Operating Expenses

$2.87 M
LEXX quarterly total operating expenses is $2.87 million

Quarterly Cost Of Goods Sold

$2700.00
LEXX quarterly cost of goods sold is $2700.00

Quarterly Interest Expense

-
LEXX quarterly interest expense value is unknown

TTM SGA

-$202.79 M
-$7.32 M-3.74%

November 30, 2024

Summary

Performance

3-Month Change

-5095.26%

1-Year Change

-5095.26%

3-Year Change

-4756.75%

5-Year Change

-4756.75%

LEXX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.93%
LEXX TTM SGA is higher than 77.93% of companies in Healthcare sector

High & Low

All-time High

-$104.70 K

3-Year Low

-$202.79 M
LEXX TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Nov 30, 2024
LEXX previous earnings announcement was published on Nov 30, 2024

Next Quarterly Earnings Report Date

Apr 9, 2025
LEXX next earnings announcement is scheduled for Apr 9, 2025

OtherLEXXexpensesmetrics:

Annual Total Expenses

$6.22 M
LEXX annual total expenses is $6.22 million

Annual Operating Expenses

$6.21 M
LEXX annual total operating expenses is $6.21 million

TTM Cost Of Goods Sold

$2700.00
LEXX TTM cost of goods sold is $2700.00

TTM Interest Expense

-
LEXX TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$3.85 M
LEXX annual SGA is $3.85 million

Annual Operating Expenses

$6.21 M
LEXX annual total operating expenses is $6.21 million

Annual Cost Of Goods Sold

$4800.00
LEXX annual cost of goods sold is $4800.00

LEXX Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+25.8%0.0%-5095.3%
3 y3 years-22.5%-3.1%-4756.8%
5 y5 years+5.7%-3.1%-4756.8%

LEXX Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-22.5%+25.8%-47.4%+98.7%-63.0%at low
5 y5-year-22.5%+25.8%-59.3%+98.7%-108.7%at low
alltimeall time-40.9%>+9999.0%-73.5%+3353.8%<-9999.0%at low

Lexaria Bioscience Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Nov 2024
-
$918.70 K(-30.4%)
$4.06 M(+5.4%)
Aug 2024
$3.85 M(+25.8%)
$1.32 M(+5.3%)
$3.85 M(+21.3%)
May 2024
-
$1.25 M(+121.1%)
$3.18 M(+15.6%)
Feb 2024
-
$567.20 K(-20.2%)
$2.75 M(-2.7%)
Nov 2023
-
$711.10 K(+10.4%)
$2.83 M(-7.7%)
Aug 2023
$3.06 M(-38.3%)
$644.40 K(-21.9%)
$3.06 M(+6.3%)
May 2023
-
$825.20 K(+28.0%)
$2.88 M(-24.3%)
Feb 2023
-
$644.50 K(-32.0%)
$3.80 M(-12.7%)
Nov 2022
-
$947.90 K(+105.0%)
$4.35 M(-12.2%)
Aug 2022
$4.96 M(-0.2%)
$462.30 K(-73.5%)
$4.96 M(-7.7%)
May 2022
-
$1.75 M(+45.9%)
$5.37 M(-8.7%)
Feb 2022
-
$1.20 M(-22.9%)
$5.88 M(+1.9%)
Nov 2021
-
$1.55 M(+77.8%)
$5.77 M(+16.1%)
Aug 2021
$4.97 M(+25.0%)
$873.60 K(-61.3%)
$4.97 M(-2.5%)
May 2021
-
$2.26 M(+107.1%)
$5.10 M(+21.8%)
Feb 2021
-
$1.09 M(+44.9%)
$4.18 M(+6.7%)
Nov 2020
-
$752.00 K(-24.9%)
$3.92 M(-1.3%)
Aug 2020
$3.98 M(+9.2%)
$1.00 M(-25.4%)
$3.97 M(+1.4%)
May 2020
-
$1.34 M(+62.2%)
$3.92 M(+9.7%)
Feb 2020
-
$827.30 K(+3.2%)
$3.57 M(-6.8%)
Nov 2019
-
$802.00 K(-15.2%)
$3.83 M(+5.2%)
Aug 2019
$3.64 M(-44.1%)
$945.50 K(-5.0%)
$3.64 M(-4.2%)
May 2019
-
$994.80 K(-8.7%)
$3.80 M(-39.4%)
Feb 2019
-
$1.09 M(+77.7%)
$6.27 M(-5.6%)
Nov 2018
-
$613.20 K(-44.5%)
$6.64 M(+2.0%)
Aug 2018
$6.51 M(+255.3%)
$1.11 M(-68.1%)
$6.51 M(+7.9%)
May 2018
-
$3.47 M(+137.5%)
$6.04 M(+106.4%)
Feb 2018
-
$1.46 M(+202.1%)
$2.93 M(+52.5%)
Nov 2017
-
$482.90 K(-23.5%)
$1.92 M(+4.7%)
Aug 2017
$1.83 M(+50.7%)
$631.20 K(+78.7%)
$1.83 M(+19.2%)
May 2017
-
$353.20 K(-21.9%)
$1.54 M(+7.3%)
Feb 2017
-
$452.10 K(+14.1%)
$1.43 M(+17.4%)
Nov 2016
-
$396.40 K(+18.0%)
$1.22 M(+0.4%)
Aug 2016
$1.22 M(-31.0%)
$336.00 K(+35.1%)
$1.22 M(-11.9%)
May 2016
-
$248.70 K(+3.9%)
$1.38 M(-15.3%)
Feb 2016
-
$239.40 K(-38.9%)
$1.63 M(-11.5%)
Nov 2015
-
$392.00 K(-21.6%)
$1.84 M(+4.4%)
Aug 2015
$1.76 M
$500.00 K(+0.4%)
$1.76 M(-4.3%)
May 2015
-
$497.90 K(+10.6%)
$1.84 M(+0.9%)
DateAnnualQuarterlyTTM
Feb 2015
-
$450.10 K(+42.9%)
$1.83 M(+32.7%)
Nov 2014
-
$315.00 K(-45.6%)
$1.38 M(+10.1%)
Aug 2014
$1.27 M(+240.1%)
-
-
Jul 2014
-
$579.50 K(+20.5%)
$1.25 M(+63.7%)
Apr 2014
-
$480.80 K(+309.5%)
$763.00 K(+107.2%)
Jan 2014
-
$117.40 K(+64.9%)
$368.20 K(-1.1%)
Oct 2013
$372.30 K(-34.2%)
$71.20 K(-23.9%)
$372.30 K(-5.3%)
Jul 2013
-
$93.60 K(+8.8%)
$393.30 K(-10.9%)
Apr 2013
-
$86.00 K(-29.2%)
$441.30 K(-14.7%)
Jan 2013
-
$121.50 K(+31.8%)
$517.40 K(-8.5%)
Oct 2012
$565.40 K(-21.4%)
$92.20 K(-34.9%)
$565.40 K(+7.7%)
Jul 2012
-
$141.60 K(-12.6%)
$524.80 K(-30.3%)
Apr 2012
-
$162.10 K(-4.4%)
$753.00 K(+6.1%)
Jan 2012
-
$169.50 K(+228.5%)
$709.70 K(+6.8%)
Oct 2011
$719.00 K(+52.0%)
$51.60 K(-86.0%)
$664.30 K(-9.7%)
Jul 2011
-
$369.80 K(+211.3%)
$735.50 K(+76.5%)
Apr 2011
-
$118.80 K(-4.3%)
$416.80 K(+14.3%)
Jan 2011
-
$124.10 K(+1.1%)
$364.70 K(-22.9%)
Oct 2010
$473.00 K(+3.1%)
$122.80 K(+140.3%)
$473.10 K(+4.6%)
Jul 2010
-
$51.10 K(-23.4%)
$452.50 K(-21.8%)
Apr 2010
-
$66.70 K(-71.3%)
$578.70 K(-8.5%)
Jan 2010
-
$232.50 K(+127.5%)
$632.60 K(+37.9%)
Oct 2009
$459.00 K(-4.3%)
$102.20 K(-42.4%)
$458.90 K(+19.7%)
Jul 2009
-
$177.30 K(+47.0%)
$383.30 K(+16.5%)
Apr 2009
-
$120.60 K(+105.1%)
$329.00 K(-3.8%)
Jan 2009
-
$58.80 K(+121.1%)
$341.90 K(-17.6%)
Oct 2008
$479.40 K(-53.5%)
$26.60 K(-78.4%)
$414.80 K(-25.1%)
Jul 2008
-
$123.00 K(-7.9%)
$553.70 K(-40.7%)
Apr 2008
-
$133.50 K(+1.4%)
$933.10 K(-17.0%)
Jan 2008
-
$131.70 K(-20.4%)
$1.12 M(+8.7%)
Oct 2007
$1.03 M(+627.9%)
$165.50 K(-67.1%)
$1.03 M(+14.1%)
Jul 2007
-
$502.40 K(+54.5%)
$907.40 K(+98.4%)
Apr 2007
-
$325.10 K(+675.9%)
$457.30 K(+182.5%)
Jan 2007
-
$41.90 K(+10.3%)
$161.90 K(+8.7%)
Oct 2006
$141.50 K(+303.1%)
$38.00 K(-27.3%)
$148.90 K(+34.3%)
Jul 2006
-
$52.30 K(+76.1%)
$110.90 K(+89.2%)
Apr 2006
-
$29.70 K(+2.8%)
$58.60 K(+102.8%)
Jan 2006
-
$28.90 K
$28.90 K
Oct 2005
$35.10 K
-
-

FAQ

  • What is Lexaria Bioscience annual SGA?
  • What is the all time high annual SGA for Lexaria Bioscience?
  • What is Lexaria Bioscience annual SGA year-on-year change?
  • What is Lexaria Bioscience quarterly SGA?
  • What is the all time high quarterly SGA for Lexaria Bioscience?
  • What is Lexaria Bioscience quarterly SGA year-on-year change?
  • What is Lexaria Bioscience TTM SGA?
  • What is the all time high TTM SGA for Lexaria Bioscience?
  • What is Lexaria Bioscience TTM SGA year-on-year change?

What is Lexaria Bioscience annual SGA?

The current annual SGA of LEXX is $3.85 M

What is the all time high annual SGA for Lexaria Bioscience?

Lexaria Bioscience all-time high annual SGA is $6.51 M

What is Lexaria Bioscience annual SGA year-on-year change?

Over the past year, LEXX annual SGA has changed by +$790.00 K (+25.80%)

What is Lexaria Bioscience quarterly SGA?

The current quarterly SGA of LEXX is $918.70 K

What is the all time high quarterly SGA for Lexaria Bioscience?

Lexaria Bioscience all-time high quarterly SGA is $3.47 M

What is Lexaria Bioscience quarterly SGA year-on-year change?

Over the past year, LEXX quarterly SGA has changed by $0.00 (0.00%)

What is Lexaria Bioscience TTM SGA?

The current TTM SGA of LEXX is -$202.79 M

What is the all time high TTM SGA for Lexaria Bioscience?

Lexaria Bioscience all-time high TTM SGA is -$104.70 K

What is Lexaria Bioscience TTM SGA year-on-year change?

Over the past year, LEXX TTM SGA has changed by -$206.85 M (-5095.26%)